DEFINITIVE PROXY STATEMENT

Company

TEVA PHARMACEUTICAL INDUSTRIES LTD

Filed

April 16, 2019

Period of Report

June 11, 2019

Accession Number

0001193125-19-107826

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →